Translating Innovations in Diabetes Drug Development is being held on the 17-19 November 2014 in London, United KingdomThe global diabetes market is projected to double from $ 32bn to $ 64bn…
drug
In an experimental model, diabetes drug shows promise in reducing Alzheimer’s disease
Researchers from Boston University School of Medicine (BUSM) have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer’s disease (AD) in the brain and improves learning and memory in two experimental AD models.
Organ transplant approach might end lifelong drug treatment
Organ-transplant recipients often reject donated organs, but a new, two-pronged strategy developed by UC San Francisco researchers to specifically weaken immune responses that target transplanted tissue has shown promise in controlled experiments on mice.